Buckbee Kevin K's Form 4 filing
AbbVie Inc. (ABBV) · filed Dec 18, 2024
- Accession no.
- 0001415889-24-029754
- Filed
- Dec 18, 2024
- Trade date
- Dec 16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $310.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Buckbee Kevin KCIK 0001968528 | Officer (SVP, CONTROLLER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Common Stock, $0.01 par value | MOption exerciseAcquired | +1,800 | $93.50 | +$168,300 | 8,783 | Direct | |
| Dec 16, 2024 | Common Stock, $0.01 par value | SSaleDisposed | −1,800 | $172.24 | −$310,032 | 6,983 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Common Stock | MOption exerciseDisposed | −1,800 | $93.50 | −$168,300 | 12,111 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.